Civil Plaintiff
Nevada Is Set to Receive a $1.7 Million Mallinckrodt Pharmaceutical Settlement
Nevada will get $1.7 million as part of a nationwide settlement with pharmaceutical giant Mallinckrodt, ending a dispute over underpaid Medicaid rebates.
Mallinckrodt, formerly Questcor, agreed to a $233.7 million settlement joined by all 50 states after allegations that the company violated the Federal False Claims Act — and the Nevada False Claims Act in the Silver State. The violations involved rebates for the drug H.P. Acthar Gel (Acthar) from Jan. 1, 2013, through June 30, 2020.
Medicaid’s drug rebate program requires manufacturers to pay the difference if a drug’s price rises faster than the rate of inflation. Acthar was originally introduced in 1952, but Mallinckrodt tried to classify it as a new drug in 2013.
